SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-23-000034
Filing Date
2023-01-04
Accepted
2023-01-04 16:13:59
Documents
7
Effectiveness Date
2023-01-04

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20230104xs8.htm S-8 85359
2 EX-4.1 tmb-20230104xex4d1.htm EX-4.1 176005
3 EX-5.1 tmb-20230104xex5d1.htm EX-5.1 12465
4 EX-23.2 tmb-20230104xex23d2.htm EX-23.2 3001
5 EX-23.3 tmb-20230104xex23d3.htm EX-23.3 3341
6 EX-FILING FEES tmb-20230104xexfilingfees.htm EX-FILING FEES 29908
7 GRAPHIC tmb-20230104xex5d1001.jpg GRAPHIC 2694
  Complete submission text file 0001558370-23-000034.txt   314930
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269114 | Film No.: 23506525
SIC: 2834 Pharmaceutical Preparations